ArticleBreast cancer research : BCR2011

Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties.

Jeffrey L Nordstrom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.